Loading viewer...
conference
Format: PDF conference
Tonix Pharmaceuticals presents pharmacokinetic data on TNX-102 SL, a novel sublingual formulation of cyclobenzaprine hydrochloride, at the 2024 Pharmaceutics and Novel Drug Delivery Systems Conference. The oral presentation by Bruce Daugherty, PhD, details the formulation development and bioavailability characteristics of this investigational drug candidate.
investor_presentation
48 Pages
conference
13 Pages
United Parcel Service of America, Inc.
Telix Pharmaceuticals 2022 JP Morgan Healthcare Conference Presentation
conferenceconference
45 Pages
Telix Pharmaceuticals Limited
Pioneer Energy Services (PES) ENERCOM Oil Gas Conference 2016
conferenceconference
23 Pages
Pioneer Energy Services Corporation